|
Symbiotec Pharmalab Ltd
|
|
secretarial@symbiotec.com Website:www.symbiotec.com
|
|
Initial public offering of up to 17,783,400 equity shares of face value of Rs. 2 each ("Equity Shares") of the company for cash at a price of Rs. 988 per equity share (including a share premium of
Rs. 986 per equity share) ("Offer Price") aggregating up to Rs. 1757.00 Crores ("Offer"). The offer comprises a fresh issue of up to 1,518,218 equity shares of face value of Rs. 2 each aggregating up to Rs.150.00 Crores by the company ("Fresh Issue") and an offer for sale of up to 16,265,182 equity shares of face value of Rs. 2 each ("Offered Shares") aggregating up to Rs.1607.00 Crores, comprising of up to 1,457,489 equity shares of face value of Rs. 2 each aggregating up to Rs. 144.00 Crores by Satwani Holdings LLP (the "Promoter Selling Shareholder"), up to 10,000,000 equity shares of face value of Rs. 2 each aggregating up to Rs.988.00 Crores by Rosewood Investments and up to 4,807,692 equity shares of face value of Rs. 2 each aggregating up to Rs. 475.00 Crores by India Business Excellence fund - III (the "Investor Selling Shareholders", and together with the promoter selling shareholder, the "Selling Shareholders" and such offer for sale of equity shares by the selling shareholders, the "Offer For Sale"). The offer will constitute [*]% of the post-offer paid up equity share capital of the company.
The offer includes a reservation of up to 30,364 equity shares of face value of Rs. 2 each aggregating up to Rs. 3 Crores (constituting up to 5% of the post offer paid-up equity share capital of the company), for subscription by eligible employees (the "Employee Reservation Portion"). The offer less the employee reservation portion is hereinafter referred to as the "Net Offer". The offer and the net offer shall constitute [*]% and [*]%, respectively, of the post-offer paid-up equity share capital of the company. The company, in consultation with the book running lead managers, may offer a discount of up to [*]% (equivalent to Rs.[*] per equity share) to the offer price to eligible employees bidding under the employee reservation portion ("Employee Discount").
The company, in consultation with the brlms, may consider a further issue of specified securities as may be permitted under applicable law, at its discretion, aggregating up to Rs.30.00 crores (the "pre-ipo placement"), prior to the filing of the pre-ipo placement, if undertaken, will be at a price to be decided by the company, in consultation with the brlms. If the pre-ipo placement is completed, the amount raised pursuant to the pre-ipo placement will be reduced from the fresh issue, subject to compliance with Rule 19(2)(b) of the securities contracts (regulation) rules, 1957, as amended ("scrr"). The pre-ipo placement, if undertaken, shall not exceed 20% of the size of the fresh issue. prior to the completion of the offer, the company shall appropriately intimate the subscribers to the pre-ipo placement, prior to allotment pursuant to the preipo
placement, that there is no guarantee that the company may proceed with the offer or that the offer may be successful and will result in the listing of the equity shares on the stock exchanges. Further, relevant disclosures in relation to such intimation to the subscribers to the pre-ipo placement (if undertaken).
Price Band: Rs. 938 to Rs. 988 per equity share of face value of Rs. 2 each.
The floor price is 469.00 times of the face value of the equity shares and the cap price is 494.00 times of the face value of the equity shares.
Bids can be made for a minimum of 15 equity shares of face value of Rs. 2 each and in multiples of 15 equity shares of face value of Rs. 2 each thereafter.
Discount of Rs. 90.00 per equity share of face value of Rs. 2 is being offered to eligible employees bidding in the employee reservation portion.
|
|
|
|
|
|
|
Symbiotec Pharmalab Ltd
|
| |
Rs Cr |
Lead Managers to the Issue |
| 0.00 |
| Avendus Capital Private Limited |
| Motilal Oswal Investment Advisors Limited |
| Nomura Financial Advisory & Securities (I) Pvt Ltd |
|
| 1757.00 |
|
| 16.10 |
|
| Rs.
938.00
|
|
|
|
|
|
| Projects |
|
Prepayment and/or repayment, in full or in part, of all or a portion of certain outstanding borrowings availed by its Company
|
General Corporate Purpose
|
|
|
| Anil Satwani |
| Kashish Satwani |
| Sushil Satwani |
|
|
| MUFG Intime India Pvt Ltd |
|
| |
|
|